These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1401771)
21. Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar). Daniel PT; Holzschuh J; Berg PA Thorax; 1989 Apr; 44(4):307-9. PubMed ID: 2763233 [TBL] [Abstract][Full Text] [Related]
22. Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug? Parikh S; Rosenthal PJ Clin Pharmacol Ther; 2010 Feb; 87(2):160-2. PubMed ID: 20107451 [TBL] [Abstract][Full Text] [Related]
23. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis. Hellgren U; Rombo L; Berg B; Carlson J; Wiholm BE Br Med J (Clin Res Ed); 1987 Aug; 295(6594):365-6. PubMed ID: 2958104 [No Abstract] [Full Text] [Related]
24. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Tagbor H; Bruce J; Browne E; Randal A; Greenwood B; Chandramohan D Lancet; 2006 Oct; 368(9544):1349-56. PubMed ID: 17046467 [TBL] [Abstract][Full Text] [Related]
25. [The reliability and side effects of malaria chemoprophylaxis]. Steffen R; Heusser R Schweiz Rundsch Med Prax; 1986 Apr; 75(16):446-8. PubMed ID: 2939527 [No Abstract] [Full Text] [Related]
26. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475 [TBL] [Abstract][Full Text] [Related]
27. Leads from the MMWR. Fansidar-associated fatal reaction in an HIV-infected man. JAMA; 1988 Oct; 260(15):2193. PubMed ID: 3262778 [No Abstract] [Full Text] [Related]
28. Human maternofoetal distribution of pyrimethamine-sulphadoxine. Trenque T; Marx C; Quereux C; Leroux B; Dupouy D; Dorangeon PH; Choisy H; Pinon JM Br J Clin Pharmacol; 1998 Feb; 45(2):179-80. PubMed ID: 9491836 [No Abstract] [Full Text] [Related]
29. [Ocular manifestations and sequelae of Lyell syndrome caused by sulfadoxine-pyrimethamine in Cameroon]. Moussala M; Binam F; Nkam M; Kouda Zeh A; Bengono G J Fr Ophtalmol; 1998 Jan; 21(1):72-7. PubMed ID: 9834901 [TBL] [Abstract][Full Text] [Related]
30. Community management of anti-malarials in Africa and iatrogenic risk. Orostegui L; Balu L; Chevret L; Habes D; Pussard E J Trop Pediatr; 2011 Jun; 57(3):225-6. PubMed ID: 20807830 [TBL] [Abstract][Full Text] [Related]
31. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069 [TBL] [Abstract][Full Text] [Related]
32. Genotoxic evaluation of the antimalarial drug, fansidar, in cultured human lymphocytes. Abou-Eisha A; Afifi M Cell Biol Toxicol; 2004 Sep; 20(5):303-11. PubMed ID: 15685933 [TBL] [Abstract][Full Text] [Related]
33. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443 [TBL] [Abstract][Full Text] [Related]
34. [Acute hepatitis following administration of fansidar]. Meier P; Schmid M; Stäubli M Schweiz Med Wochenschr; 1990 Feb; 120(7):221-5. PubMed ID: 2309111 [TBL] [Abstract][Full Text] [Related]
35. [Stevens-Johnson syndrome in a patient treated with quinine and pyrimethamine-sulfadoxine]. Gascón Brustenga J; Merlos Pujol A; Bada Ainsa JL Med Clin (Barc); 1986 Dec; 87(19):821-2. PubMed ID: 3821238 [No Abstract] [Full Text] [Related]
36. Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person. Raviglione MC; Dinan WA; Pablos-Mendez A; Palagiano A; Sabatini MT Arch Intern Med; 1988 Dec; 148(12):2683-5. PubMed ID: 3264143 [TBL] [Abstract][Full Text] [Related]